Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Prochlorperazine mesilate
Sanofi
N05AB04
Prochlorperazine mesilate
12.5mg/1ml
Solution for injection
Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 04060000; GTIN: 5000283652434
_I_ IF YOU MISS A DOSE OF STEMETIL INJECTION Your doctor or nurse will have instructions on when to give you this medicine. It is unlikely that you will not be given the medicine as it has been prescribed. However, if you do think you have missed a dose, tell your doctor or nurse. IF YOU STOP HAVING STEMETIL INJECTION Keep having Stemetil Injection until your doctor tells you to stop. If you stop having Stemetil Injection, your illness may come back and you may have other effects such as feeling or being sick or difficulty sleeping. Your doctor will gradually stop your medicine to prevent these effects happening. EXPOSURE TO SUNLIGHT Stemetil Injection can cause your skin to be more sensitive to sunlight. You should avoid exposure to direct sunlight while having this medicine. TESTS Your doctor may do regular tests while you are having this medicine. These might include blood tests and an ECG to check your heart is working properly. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Stemetil Injection can cause side effects, although not everybody gets them. TELL A DOCTOR OR NURSE STRAIGHT AWAY IF: • You have an allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue HOW MUCH STEMETIL INJECTION IS GIVEN If you are not sure why you are being given Stemetil Injection or have any questions about how much Stemetil Injection is being given to you, speak to your doctor or nurse. The usual doses are: SCHIZOPHRENIA AND OVERACTIVE BEHAVIOUR OR THOUGHTS (MANIA) Adults: 12.5 - 25 mg two or three times a day. You will be given injections until you are able to take Stemetil Tablets or syrup STOPPING YOU FEELING SICK OR BEING SICK: Adults: To begin with 12.5 mg by injection. This may be followed by oral medication 6 hours later if necessary Elderly: Your doctor may prescribe a lower dose. You should be careful during very hot or very cold weather to make sure that yo Read the complete document
OBJECT 1 STEMETIL INJECTION Summary of Product Characteristics Updated 27-Jul-2016 | SANOFI 1. Name of the medicinal product Stemetil 12.5mg/ml Injection 2. Qualitative and quantitative composition Each 1 ml of Stemetil injection contains 12.5 mg prochlorperazine mesilate. Excipients: Each 1 ml of Stemetil injection contains 1 mg of sodium sulphite, 0.75 mg of sodium metabisulphite and 6 mg of sodium chloride. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Colourless sterile solution. 4. Clinical particulars 4.1 Therapeutic indications Stemetil is a potent phenothiazine neuroleptic. Uses: The treatment of nausea and vomiting and in schizophrenia (particularly the chronic stage) and acute mania. 4.2 Posology and method of administration ADULTS For deep intramuscular injection. INDICATION DOSAGE Treatment of nausea and vomiting 12.5 mg by deep i.m. injection followed by oral medication 6 hours later if necessary. Schizophrenia and other psychotic disorders 12.5 mg to 25 mg b.i.d. or t.d.s. by deep i.m. injection until oral treatment becomes possible. CHILDREN Intramuscular Stemetil should not be given to children. ELDERLY A lower dose is recommended (see section 4.4). 4.3 Contraindications Known hypersensitivity to prochlorperazine or to any of the other ingredients. The use of Stemetil injection is contraindicated in children as it has been associated with dystonic reactions after the cumulative dose of 0.5 mg/kg. 4.4 Special warnings and precautions for use Stemetil should be avoided in patients with liver or renal dysfunction, Parkinson's disease, hypothyroidism, cardiac failure, phaeochromocytoma, myasthenia gravis, prostate hypertrophy. It should be avoided in patients known to be hypersensitive to phenothiazines or with a history of narrow angle glaucoma or agranulocytosis. Close monitoring is required in patients with epilepsy or a history of seizures, as phenothiazines may lower the seizure threshold. As agranulocytosis has been reported, regular monitoring of the complete blood coun Read the complete document